Kewaunee Scientific Corp. KEQU
Medical Specialities · data as of November 13, 2026
Kewaunee Scientific Corp. (KEQU) is a industrial company listed in the US with a market value of about $103M. In the twelve months to July 31, 2026 it had revenue of $277M and net income of $8M, a net margin of 3.0%.
Its overall Stock Analiz score is 2.2 out of 5 (weak). The strongest part is value (4/5); the weakest is future growth (1/5).
Key numbers: a P/E of 12.9, a price to free cash flow of 9.5, 5-year revenue growth of 14% a year, a 5-year average ROIC of 10%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 15% above the current price.
About Kewaunee Scientific
Kewaunee Scientific is listed in the US and classified in medical specialities. Revenue went from $119M in 2015 to $282M in 2026, growth of about 8.2% a year. It was profitable in 7 of the last 10 years in our data. Its share count rose by 3% over three years (dilution for shareholders). It spends 0% of revenue on research and development.
Score: 2.2 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Positive free cash flow
Checks not passed
- PEG below 1.5
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $277M | $282M | $240M | $204M | $219M | $169M | $147M | $148M | $147M | $158M | $139M |
| Net income | $8M | $10M | $11M | $19M | $738000 | -$6M | -$4M | -$5M | $2M | $5M | $5M |
| Free cash flow | $11M | $15M | $13M | $15M | -$8M | -$10M | -$1M | $2M | -$2M | -$212000 | $9M |
| EPS (diluted) | $2.76 | $3.22 | $3.83 | $6.38 | $0.25 | $-2.20 | $-1.33 | $-1.70 | $0.55 | $1.90 | $1.66 |
| Net margin | 3.0% | 3.4% | 4.7% | 9.2% | 0.3% | -3.6% | -2.5% | -3.2% | 1.0% | 3.3% | 3.3% |
| ROIC | — | 12.2% | 12.2% | 22.1% | 8.5% | -4.6% | -1.8% | -3.9% | 3.4% | 11.2% | 9.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
What is Kewaunee Scientific’s P/E ratio?
About 12.9, based on the last twelve months of diluted earnings per share.
Is Kewaunee Scientific stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 15% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Kewaunee Scientific pay a dividend?
Not currently.
Is Kewaunee Scientific a good stock to buy?
We do not give buy or sell advice. Kewaunee Scientific scores 2.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.